<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381582/" ref="ordinalpos=3068&amp;ncbi_uid=7400237&amp;link_uid=PMC4381582" image-link="/pmc/articles/PMC4381582/figure/F6/" class="imagepopup">Figure 6. PCTK1 inhibition alters Akt/mTOR <span class="highlight" style="background-color:">pathway</span> in c-Myc hallmarked MB cell lines.  From: RNA interference screening identifies a novel role for PCTK1/CDK16 in medulloblastoma with c-Myc amplification. </a></div><br /><div class="p4l_captionBody">A. Analysis of signaling pathway regulators protein level upon treatment with PCTK1 inhibitor in DAOY V11 and M2.1 and B. in D458 cells C. PCTK1 inhibition induces cell death in dose dependent manner as shown by trypan blue staining and D. sub-G1 cell accumulation.</div></div>